DexCom (DXCM) Tops Q2 EPS by 9c ; Offers Guidance
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $90.58 -0.24%
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Financial Fact:
Product cost of sales: 47.5M
Today's EPS Names:
OFLX, VAXX, NMRD, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.70, $0.09 better than the analyst estimate of $0.61. Revenue for the quarter came in at $1.31 billion versus the consensus estimate of $1.29 billion.
GUIDANCE:
DexCom sees FY2026 revenue of $5.18-5.25 billion, versus the consensus of $5.22 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Sandisk targets mid-to-high teens revenue growth through FY2030
- Tencent Holdings (700:HK) (TCEHY) PT Lowered to HK$625 at Benchmark to Reflect Downward Earnings Revisions
- Activist investors push Seer, Inc. to disclose go-private timeline
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
